Big pharma gets a boost as China speeds up new drug approvals
Data from overseas clinical trials can now be used for drug registrations in China
Tue, Oct 10, 2017 - 5:50 AM
Faster approvals could deliver a revenue boost to multinational pharmaceutical firms that are expanding in China.
FOR decades, Chinese patients have struggled to gain access to cutting edge medicines thanks to bureaucratic delays that have hamstrung drug development. Now, a sweeping government overhaul of drug approvals is poised to change that.